Malcolm Wilson

The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

Malcolm has been a Consultant Colorectal and Peritoneal Oncology Surgeon at the Christie Hospital NHS Foundation Trust since 2000. Having been Clinical Director for Surgery, Christie Hospital from 2006-2014 and Lead Clinician for Colorectal Cancer, Christie Hospital from 2016-2018, he has been the Joint Lead of the Peritoneal Tumour Service, Christie Hospital since 2002. Malcolm am a Senior Lecturer at the Dept of Medicine, University of Manchester. His unit was awarded Cancer Care Team of the year at the BMJ Awards in 2013 for its work in the care of patients with colorectal peritoneal metastases.

dont miss

Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

The aim will be to give an overview in the management of peritoneal disease from both appendiceal and colorectal tumours. This will pay particular attention to the use of cytoreductive surgery and heated intra-peritoneal chemotherapy (HIPEC) and will draw on my unit’s experience of being one of the National Centres in the UK that treats this. We have performed over 1250 cases over the last 18 years and now perform 155-160 cases per year.


  • Mr Richard Steyn: Speaking at the Oncology Convention

    Mr Richard Steyn
    UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

    Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

  • Dr Sileida Oliveros: Speaking at the Oncology Convention

    Dr Sileida Oliveros

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment

  • Hamed Javan MD: Speaking at the Oncology Convention

    Hamed Javan MD
    Jewish General Hospital

    Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer

  • Odette Woods  <br >  AGSM, PgDipRNCM, RGN: Speaking at the Oncology Convention

    Odette Woods

    Cancer Hopeline

    Empowering Cancer Patients to Optimal Treatment Outcomes and Prognosis

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt